treatment of the hybrid cells with bacterial lipopolysaccharide ( lps ) , increases the nf-kappa b titer 4- to 5-fold and causes a concomitant 4- to 5-fold increase in kappa enhancer activity within these cells .
C0086222
enhancer
C0007634
cells